Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer.

BMC Cancer · 2024 · PMC11490043 · PMID 39425079

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

4.2%, P = 1.000 > 0.05), these difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.